Takeda Pharmaceutical Income Statement (2017-2025) | TAK

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue	4.32B	3.70B	4,125.62B	3,866.76B	0.00B	0.01B	7.72B	7.56B	7.91B	7.80B	7.46B	7.43B	8.01B	7.28B	8.67B	7.67B	7.93B	8.37B	7.52B	7.26B	7.76B	8.00B	7.72B	7.69B	7.11B	7.09B	7.76B	23.65B	6.92B	7.92B	8.13B	23.95B	7.74B
Cost of Revenue	1.26B	1.02B	1,106.16B	994.52B	1.23B	0.00	2.65B	2.52B	2.57B	2.68B	2.21B	2.35B	2.42B	2.39B	2.20B	2.51B	2.48B	2.52B	2.26B	2.21B	2.38B	2.43B	2.34B	2.63B	2.58B	2.58B	2.49B	8.03B	2.52B	2.54B	2.73B	8.13B	2.61B
Gross Profit	3.06B	2.68B	3,019.46B	2.87	-1.23B	2.99	5,068.13B	5,039.87B	5.33B	5.81B	5.24B	17.39B	5.59B	4.88B	6.47B	5.17B	5.45B	5.85B	5.48B	15.71B	4.60B	5.57B	5.17B	5.31B	4.52B	4.51B	5.02B	15.62B	4.40B	5.38B	5.40B	15.81B	5.14B
Operating items
Amortization - Intangibles						-0.22				-0.97B		-2.92B
Research & Development	-0.72B	5.19B	-0.66	-0.71	-0.69B	1.06B	-1.06B	-1.06B	-1.13B	7.77B	-0.99B	-1.11B	-1.13B	7.54B	-1.12B	-1.20B	-1.13B	-1.24B	-1.11B	-1.12B	-1.24B	-1.23B	-1.19B	-1.27B	-1.27B	8.53B	-1.08B	-1.18B	-1.12B	8.16B	-0.99B	-1.10B	-1.14B
Selling, General & Administrative	-1.41B	4.33B	-1.33	-1.34	-1.36B	2.17B	-2.18B	-2.08B	-2.29B	-2.20B	-1.88B	-2.04B	-2.13B	6.45B	-2.01B	-1.93B	-2.03B	-1.99B	-1.79B	-1.80B	-1.86B	-1.88B	-1.81B	-1.85B	-1.92B	5.76B	-1.73B	-5.42B	-1.95B	-1.77B	-1.85B	-5.49B	-1.84B
Restructuring Costs						0.09B
Operating Expenses	-2.13B	9.52B	-1.99	-2.05	-2.05B	3.32B	-3.24B	-3.14B	-3.42B	5.57B	-2.87B	-3.15B	-3.26B	13.99B	-3.13B	-3.12B	-3.16B	-3.23B	-2.90B	-2.92B	-3.09B	-3.11B	-3.00B	-3.13B	-3.19B	14.29B	-2.82B	-6.60B	-3.07B	6.39B	-2.85B	-6.59B	-2.98B
Operating Income	0.78B	-0.74B	907.12B	656.13B	1.00B	0.90B	0.41B	0.60B	0.49B	2.60B	1.56B	0.45B	1.37B	1.42B	2.27B	0.89B	1.02B	2.14B	1.16B	0.76B	1.04B	1.27B	1.23B	2.28B	1.58B	-0.07B	1.07B	6.75B	1.25B	2.51B	2.33B	6.83B	1.10B
EBIT	0.78B	-0.74B	907.12B	656.13B	1.00B	0.90B	0.41B	0.60B	0.49B	2.60B	1.56B	0.45B	1.37B	1.42B	2.27B	0.89B	1.02B	2.14B	1.16B	0.76B	1.04B	1.27B	1.23B	2.28B	1.58B	-0.07B	1.07B	6.75B	1.25B	2.51B	2.33B	6.83B	1.10B
Non-operating items
Interest & Investment Income	0.07B	0.16B	0.06	0.02	0.05B	0.08B	0.08B	0.08B	0.31B	-0.04B	0.18B	0.09B	0.27B	0.45B	0.42B	0.06B	0.04B	-0.17B	0.47B	0.11B	0.30B	0.20B	0.19B	0.27B	0.09B	0.04B	0.20B	0.31B	0.08B	0.48B	0.31B	1.40B	0.57B
Non Operating Income						-0.08				-0.34B		-0.94B
Net income details
EBT	0.49B	-0.65B	0.86	0.60	0.42B	2.25B	0.09B	0.20B	0.23B	2.33B	1.21B	-0.04B	1.05B	1.24B	2.04B	0.56B	0.64B	1.92B	1.20B	0.47B	0.76B	1.18B	0.99B	2.03B	1.42B	-0.32B	0.88B	6.04B	1.03B	2.31B	2.04B	6.12B	0.87B
Tax Provisions	0.12B	0.72B	-0.14	-0.17	-0.09B	-0.14B	0.03B	0.44B	-0.52B	-0.50B	-0.44B	0.08B	-0.17B	-0.63B	-0.78B	-0.14B	-0.13B	-0.73B	0.39B	-0.02B	0.08B	-0.38B	0.33B	-0.22B	-0.34B	-0.93B	-0.27B	-1.36B	-0.29B	-0.50B	-0.58B	-1.38B	-0.20B
Profit After Tax	0.60B	-0.50B	0.72	0.43	0.34B	0.71B	0.06B	0.63B	-0.30B	1.82B	0.77B	0.04B	0.88B	1.86B	1.26B	0.42B	0.51B	1.18B	0.81B	0.45B	0.84B	0.79B	0.65B	1.80B	1.08B	-0.02B	0.61B	4.69B	0.74B	1.81B	1.47B	4.74B	0.67B
Equity Income	-0.30B	0.01B	0.03	0.00	-0.43B	0.03B	0.02B	0.02B	-0.18B	-0.08B	0.09B	0.01B	0.01B	0.08B	-0.00B	-0.03B	-0.02B	-0.00B	-0.00B	-0.01B	-0.01B	-0.00B	-0.00B	0.01B	-0.02B	0.03B	0.00B	0.03B	0.01B	0.00B	0.01B	0.01B	0.03B
Income from Non-Controlling Interests	0.00B	-0.01B	0.00		0.00B	0.00	0.00B	0.00B	0.00B		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B		0.00B			0.00B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.01B
Income from Continuing Operations	0.37B	-1.37B	1.01	0.77	0.51B	2.40B	0.06B	-0.24B	0.75B	2.83B	1.66B	-0.13B	1.22B	1.86B	2.82B	0.70B	0.76B	2.65B	0.81B	0.49B	0.67B	1.56B	0.65B	2.25B	1.76B	0.61B	1.14B	7.40B	1.32B	2.81B	2.62B	7.49B	1.07B
Consolidated Net Income	0.37B	-1.37B	1.01	0.77	0.51B	2.40B	0.06B	-0.24B	0.75B	2.83B	1.66B	-0.13B	1.22B	1.86B	2.82B	0.70B	0.76B	2.65B	0.81B	0.49B	0.67B	1.56B	0.65B	2.25B	1.76B	0.61B	1.14B	7.40B	1.32B	2.81B	2.62B	7.49B	1.07B
Income towards Parent Company	0.83B	-1.63B	0.72	0.43	0.33B	-0.27B	0.06B	0.63B	-0.30B	0.02B	0.77B	0.04B	0.88B	1.86B	1.26B	0.42B	0.51B	-0.10B	0.81B	0.45B	0.84B	1.76B	0.65B	1.80B	1.08B	-0.02B	0.61B	4.69B	0.74B	1.81B	1.47B	4.74B	0.67B
Net Income towards Common Stockholders	0.83B	-1.63B	0.72	0.43	0.33B	-0.27B	0.06B	0.63B	-0.30B	0.02B	0.77B	0.04B	0.88B	1.86B	1.26B	0.42B	0.51B	-0.10B	0.81B	0.45B	0.84B	1.76B	0.65B	1.80B	1.08B	-0.02B	0.61B	4.69B	0.74B	1.81B	1.47B	4.74B	0.67B
Additional items
EPS (Basic)	0.30B		0.78	0.78	0.00B	-0.26B	1.55B	1.41B	-1.18B	0.06B	1.56B	0.07B	0.81B	0.82B	1.57B	0.39B	0.37B	-0.08B	1.55B	0.57B	0.65B	1.14B	1.55B	9.83B	1.69B	-0.03B	1.57B	5.88B	0.85B	4.05B	2.67B	9.77B	0.75B
EPS (Weighted Average and Diluted)	0.31B		0.79	0.30	0.00B	-0.26B	1.56B	1.41B	-1.19B	0.06B	1.57B	0.07B	0.81B	0.82B	1.57B	0.39B	0.38B	-0.08B	1.55B	0.58B	0.65B	1.16B	1.57B	9.91B	1.71B	-0.03B	1.59B	5.97B	0.86B	4.12B	2.71B	9.92B	0.77B
Shares Outstanding (Weighted Average)	2.73		0.92	0.55	1.86	1.03	0.04	0.45	0.25	0.26	0.49	0.52	1.10	2.27	0.80	1.06	1.36	1.27	0.53	0.78	1.30	1.54	0.42	0.18	0.64	0.62	0.39	0.80	0.88	0.45	0.55	0.49	0.89
Shares Outstanding (Diluted Average)	2.71		0.91	1.44	1.85	1.03	0.04	0.45	0.25	0.26	0.49	0.52	1.09	2.26	0.80	1.06	1.35	1.26	0.52	0.77	1.29	1.53	0.42	0.18	0.63	0.62	0.39	0.79	0.87	0.44	0.54	0.48	0.88
EBITDA	0.83B	-0.74B	907.12B	656.13B	-0.56B	-0.41B	0.41B	0.60B	0.49B	2.60B	1.56B	0.45B	1.37B	1.42B	2.27B	0.89B	1.02B	2.14B	1.16B	0.76B	1.04B	1.27B	1.23B	2.28B	1.58B	-0.07B	1.07B	6.75B	1.25B	2.51B	2.33B	6.83B	1.10B
Interest Expenses	-0.06B	0.50B	-0.14	-0.08	-0.20B	0.42B	-0.42B	-0.50B	-0.40B	2.65B	-0.44B	-0.60B	-0.60B	3.99B	-0.65B	-0.36B	-0.41B	2.67B	-0.43B	-0.39B	-0.56B	-0.41B	-0.43B	-0.53B	-0.28B	2.65B	-0.38B	-1.03B	-0.31B	-0.68B	-0.56B	-2.07B	-0.80B
Tax Rate	23.89%	-109.92%	-16.83%	-27.65%	-20.45%	-6.37%	30.47%	222.08%	-229.24%	-21.67%	-36.67%	-186.05%	-15.81%	-50.63%	-38.23%	-25.15%	-19.91%	-38.25%	32.45%	-4.36%	11.20%	-32.48%	33.79%	-10.94%	-24.11%	290.99%	-30.24%	-22.47%	-28.62%	-21.47%	-28.17%	-22.47%	-22.51%

Research Tools

Takeda Pharmaceutical Income Statement (2017-2025) | TAK

Create an account

Sign In

Reset Password